(r)5oxopyrrolidine2carboxylic acid

(R)-5-Oxopyrrolidine-2-carboxylic acid (D-Pyroglutamic acid) is a cyclic derivative of glutamic acid, physiologically present in mammalian tissues. It releases GABA from the cerebral cortex and exhibits anti-anxiety effects in a simple approach-avoidance conflict situation in rats. In clinical pharmacology experiments, it significantly shortens the plasma half-life of ethanol during acute intoxication.

L-Pyroglutamic acid-d5 is the deuterated form of L-Pyroglutamic acid. The compound L-Pyroglutamic acid represents the levorotatory isomer of Pyroglutamic acid and is the biologically active enantiomer present in the human body. Pyroglutamic acid serves as an intermediate in the metabolism of glutathione.

Sodium L-pyroglutamate is a biochemical reagent used as a biological material or organic compound in life science research.

L-Pyroglutamic acid-13C5 is the deuterium-labeled version of L-Pyroglutamic acid. This compound is the levorotatory isomer of Pyroglutamic acid, which acts as the biologically active enantiomer within the human body. Additionally, Pyroglutamic acid serves as an intermediate in the metabolism of glutathione.

DL-Pyroglutamic acid exhibited a strong inactivating effect on hepatitis B surface antigen.

L-Pyroglutamic acid (pidolic acid), a cyclized derivative of the L-GLUTAMIC ACID, can elevate blood levels. This function may be associated with problems of GLUTATHIONE or GLUTAMINE metabolism.

L-Pyroglutamic acid (Standard) is the standard substance of L-Pyroglutamic acid, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. L-Pyroglutamic acid (pidolic acid), a cyclized derivative of the L-GLUTAMIC ACID, can elevate blood levels. This function may be associated with problems of GLUTATHIONE or GLUTAMINE metabolism.